Transition from First Illicit Drug Use to First Injection Drug Use Among Rural Appalachian Drug Users: a Cross-sectional Comparison and Retrospective Survival Analysis

Overview

Journal Addiction

Specialty Psychiatry

Date 2011 Sep 3

PMID 21883604

Citations 98

Authors

April M Young

Jennifer R Havens

Affiliations

Soon will be listed here.

Abstract

Aim: The study's objectives were to characterize initiation of injection drug use, examine the independent association of specific substance use with injection drug use and determine factors associated with rates of transition from first illicit drug use to first injection among a sample of rural Appalachian drug users.

Design: Interview-administered questionnaires were administered to a sample of drug users recruited via respondent-driven sampling.

Setting: Appalachian Kentucky.

Participants: Injection drug users (IDUs) (n = 394) and non-IDUs (n = 109).

Measurements: Data were collected on substance use and years from age at initiation of illicit substance use to 'event' (initiation of injection or date of baseline interview for non-IDUs). Logistic regression and Cox regression were used to identify factors associated with life-time injection drug use and transition time to injection, respectively.

Findings: OxyContin(®) was involved in nearly as many initiations to injection (48%), as were stimulants, other prescription opioids and heroin combined; for participants who initiated with OxyContin(®), the median time from which they began OxyContin(®) use to their first injection of OxyContin(®) was 3 years. Adjusting for demographics, five prescription drugs (benzodiazepines, illicit methadone, oxycodone, OxyContin(®) and other opiates) were associated with an increased hazard for transitioning from first illicit drug use to first injection drug use (each at P < 0.01).

Conclusions: In Appalachia, in the United States, the prescription opioid OxyContin(®) is widely used non-medically and appears to show a particularly high risk of rapid transition to injection compared with the use of other illicit drugs.

Citing Articles

Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018-2020.

Ibragimov U, Livingston M, Young A, Feinberg J, Korthuis P, Akhtar W AIDS Behav. 2023; 28(1):59-71.

PMID: 37515742 PMC: 10823036. DOI: 10.1007/s10461-023-04140-x.

The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis.

Jenkins R, Whitney B, Nance R, Allen T, Cooper H, Feinberg J Addict Sci Clin Pract. 2022; 17(1):38.

PMID: 35883197 PMC: 9321271. DOI: 10.1186/s13722-022-00322-5.

The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.

Dickson-Gomez J, Krechel S, Spector A, Weeks M, Ohlrich J, Green Montaque H Subst Abuse Treat Prev Policy. 2022; 17(1):55.

PMID: 35864522 PMC: 9306091. DOI: 10.1186/s13011-022-00480-4.

Recent Incarceration Among Individuals Infected With Hepatitis A Virus During Person-to-Person Community Outbreaks, United States, 2016-2020.

Hagan L, Montgomery M, Lauro P, Cima M, Stringer G, Kupferman N Public Health Rep. 2022; 138(4):619-624.

PMID: 35856418 PMC: 10291163. DOI: 10.1177/00333549221108413.

Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir.

Sonti S, Tyagi K, Pande A, Daniel R, Sharma A, Tyagi M Vaccines (Basel). 2022; 10(2).

PMID: 35214661 PMC: 8875185. DOI: 10.3390/vaccines10020202.

References

Strang J, Griffiths P, Gossop M . Heroin in the United Kingdom: different forms, different origins, and the relationship to different routes of administration. Drug Alcohol Rev. 2005; 16(4):329-37. DOI: 10.1080/09595239700186711. View

Fuller C, Vlahov D, Ompad D, Shah N, Arria A, Strathdee S . High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002; 66(2):189-98. DOI: 10.1016/s0376-8716(01)00200-9. View

Strang J, Griffiths P, Powis B, ABBEY J, Gossop M . How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug Alcohol Depend. 1997; 46(1-2):115-8. DOI: 10.1016/s0376-8716(97)00035-5. View

Walsh S, Nuzzo P, Lofwall M, Holtman Jr J . The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug Alcohol Depend. 2008; 98(3):191-202. PMC: 2668197. DOI: 10.1016/j.drugalcdep.2008.05.007. View

Fennema J, van Ameijden E, van den Hoek A, Coutinho R . Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1998; 92(11):1457-65. View

Young A, Havens J, Leukefeld C . Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J. 2010; 7:24. PMC: 2967505. DOI: 10.1186/1477-7517-7-24. View

Stoops W, Hatton K, Lofwall M, Nuzzo P, Walsh S . Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies. Psychopharmacology (Berl). 2010; 212(2):193-203. PMC: 2939200. DOI: 10.1007/s00213-010-1942-4. View

Strang J, Des Jarlais D, Griffiths P, Gossop M . The study of transitions in the route of drug use: the route from one route to another. Br J Addict. 1992; 87(3):473-83. DOI: 10.1111/j.1360-0443.1992.tb01948.x. View

Gossop M, Griffiths P, Powis B, Strang J . Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict. 1992; 87(11):1527-36. DOI: 10.1111/j.1360-0443.1992.tb02660.x. View

10.

Grau L, Dasgupta N, Harvey A, Irwin K, Givens A, Kinzly M . Illicit use of opioids: is OxyContin a "gateway drug"?. Am J Addict. 2007; 16(3):166-73. DOI: 10.1080/10550490701375293. View

11.

Nelson K, Galai N, Safaeian M, Strathdee S, Celentano D, Vlahov D . Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002; 156(7):641-53. DOI: 10.1093/aje/kwf086. View

12.

Obot I, Anthony J . School dropout and injecting drug use in a national sample of white non-Hispanic American adults. J Drug Educ. 2000; 30(2):145-55. DOI: 10.2190/42V8-TYRJ-N8C3-WAHU. View

13.

Abelson J, Treloar C, Crawford J, Kippax S, van Beek I, Howard J . Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006; 101(4):548-55. DOI: 10.1111/j.1360-0443.2006.01379.x. View

14.

van Ameijden E, van den Hoek J, Hartgers C, Coutinho R . Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994; 139(12):1153-63. DOI: 10.1093/oxfordjournals.aje.a116962. View

15.

Cooper H, Bossak B, Tempalski B, Des Jarlais D, Friedman S . Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes. Int J Drug Policy. 2008; 20(3):217-26. PMC: 2776775. DOI: 10.1016/j.drugpo.2008.08.008. View

16.

Cicero T, Surratt H, Inciardi J, Munoz A . Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007; 16(8):827-40. DOI: 10.1002/pds.1452. View

17.

Griffiths P, Gossop M, Powis B, Strang J . Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction. 1994; 89(3):301-9. DOI: 10.1111/j.1360-0443.1994.tb00896.x. View

18.

Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin J . Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003; 80(1):92-105. PMC: 3456111. DOI: 10.1093/jurban/jtg092. View

19.

McMahon J, Pouget E, Tortu S . Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. J Infect Dis. 2007; 195(11):1572-81. DOI: 10.1086/516785. View

20.

Gossop M, Griffiths P, Powis B, Williamson S, Strang J . Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996; 313(7054):402. PMC: 2351798. DOI: 10.1136/bmj.313.7054.402. View